In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study.

Source:http://linkedlifedata.com/resource/pubmed/id/19449027

Download in:

View as

General Info

PMID
19449027